Mode
Text Size
Log in / Sign up
N/A N=87 Randomized Treatment

Neurofeedback Impact on Veterans With mTBI

Concussion · mTBI · Post-Concussive Symptoms · Chronic Headache · Chronic Insomnia

Enrolled (actual)
87
Serious AEs
2.3%
Results posted
Oct 2025
Primary outcome: Primary: Headache Impact Test (HIT-6) — 53.2; 61.4; 49.2; 60.9 score on a scale — p=<.0001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Neurofeedback (NFB) (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Sep 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Headache Impact Test (HIT-6)
53.2; 61.4; 49.2; 60.9; 52.2; 62.6 <.0001 sig
PRIMARY
NEUROQOLTBI Headache Pain Short Form
21.3; 28.5; 18.9; 28.0; 23.1; 32.4 <.0001 sig
PRIMARY
Insomnia Severity Index (ISI)
11.5; 17.2; 7.7; 17.1; 10.2; 17.0 <.0001 sig
PRIMARY
NEUROQOLTBI Sleep Disturbance Short Form
29.2; 22.0; 31.2; 22.3; 28.6; 22.7 <.0001 sig
PRIMARY
QIKtest Continuous Performance Test - Accuracy Index
252.0; 241.6; 271.4; 247.3; 254.4; 256.8 0.0022 sig
PRIMARY
Quality of Life After Brain Injury (QOLIBRI)
127.4; 106.8; 139.8; 107.6; 133.8; 108.6 <.0001 sig
PRIMARY
NEUROQOLTBI Satisfaction With Social Roles and Activities Short Form
33.5; 30.0; 35.4; 31.2; 34.8; 30.0 0.0002 sig
PRIMARY
NEUROQOLTBI Ability to Participate in Social Roles and Activities Short Form
29.1; 24.7; 31.0; 24.2; 29.7; 24.8 <.0001 sig
PRIMARY
NEUROQOLTBI Positive Affect and Well-being-short Form
33.5; 30.2; 35.5; 31.0; 34.7; 30.1 0.0033 sig
SECONDARY
Depression, Anxiety and Stress Scale 21 (DASS21)
12.0; 20.3; 10.2; 19.9; 13.3; 23.1 0.0005 sig
SECONDARY
Patient Health Questionnaire-9 (PHQ-9)
8.2; 12.2; 5.7; 12.0; 7.4; 13.1 <.0001 sig
SECONDARY
Posttraumatic Stress Disorder Checklist (PCL-5)
25.4; 35.7; 19.3; 33.7; 23.0; 37.1 0.0001 sig
SECONDARY
General Symptom Inventory (GSI)
108.7; 151.7; 81.3; 139.4; 103.1; 150.4 <.0001 sig

Summary

This study will evaluate neurofeedback (NFB) training as a low risk, non-invasive, effective treatment for Veterans diagnosed with mild traumatic brain injury (mTBI) and experiencing chronic post-concussive symptoms (PCSs). Participants will be randomized into the intervention or control group. Groups will be compared on primary measures of headache, insomnia and attention. Other outcomes of interest include post-traumatic stress symptoms, depression, quality of life and other measures of well-being.

Eligibility Criteria

Inclusion Criteria

  • Male and non-pregnant female OEF-OIF-OND Veterans diagnosed with mTBI ages 18 to 65
  • Complaints of chronic headaches, insomnia, and attention difficulties
  • Able to read and write English
  • Able to comprehend what they read
  • Able to follow directions

Exclusion Criteria

  • Pregnant female Veteran
  • Non OEF-OIF-OND Veteran who is diagnosed with mTBI
  • Under the age of 18 or over the age of 65
  • Severe TBI
  • Impaired decision-making capacity
  • Unable to comply with study visit schedule
  • Suicide Intent as indicated by a positive response to questions 3, 4, 5, or 8 on the Columbia Suicide Severity Rating Scale (C-SSRS) secondary screen
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04195685). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search